Your feedback matters and will make a difference. Help us understand your digital experience by taking our 10 minute survey. Your responses are completely anonymous. Start the survey.
Document
Summary
This service specification also covers children with suspected Multiple Sclerosis (MS) or equally rare ‘MS-like’, recurrent acquired demyelinating syndromes (ADS) or who have had a first demyelination episode and have a high risk of relapse which require similar treatments, including:
- Neuromyelitis Optica Spectrum Disorder (NMO, NMOSD) and other AQP4 antibody associated demyelination;
- Myelin Oligodendrocyte Glycoprotein (MOG) antibody associated relapsing demyelination and
- Other forms of recurrent relapsing demyelination.